Ataxia Telangiectasia Market to Register Sustainable Growth During the Forecast Period (2019-32) – Estimates DelveInsight | Key Companies – EryDel, IntraBio, and Several Others

August 19 21:28 2022
Ataxia Telangiectasia Market to Register Sustainable Growth During the Forecast Period (2019-32) - Estimates DelveInsight | Key Companies - EryDel, IntraBio, and Several Others
Delveinsight Business Research LLP
As per DelveInsight, the Ataxia Telangiectasia Therapeutics Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies, ongoing Research and Development (R&D) activities, and the active participation of the global pharma and biotech giants in the therapeutic segment. Several key companies are active in the therapeutic domain, and the therapies under development are focused on novel approaches to treat the disease.

DelveInsight’s “Ataxia Telangiectasia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Ataxia Telangiectasia Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Ataxia Telangiectasia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Ataxia Telangiectasia Market

Ataxia Telangiectasia: An Overview

Ataxia-Telangiectasia (A-T) is a rare inherited disorder that affects the nervous system, immune system, and other body systems. This disorder is characterized by progressive difficulty in coordinating movements (ataxia) beginning in early childhood, usually before age 5. Affected individuals tend to have a high amount of a protein called alpha-fetoprotein (AFP) in their blood. It is categorized as Typical (childhood-onset) and Atypical (adult-onset).

Ataxia Telangiectasia Market Key Fact

  • As per the National Library of Medicine (2018), Ataxia-Telangiectasia occurs in 1 in 40,000–100,000 people worldwide.

  • According to the National Organization for Rare Disorders (2018), males and females are equally affected. In the United States, the prevalence is approximately 1 in 40,000–100,000 live births.

  • The Orphanet Registry (2018) estimates the average prevalence of Ataxia-Telangiectasia at 1 per 100,000 children. The most reliable estimates for the number of people with Ataxia Telangiectasia, in the UK at least, are 3 per million.

  • As per Jayesh et al., in 2015, the prevalence of patients with Ataxia-Telangiectasia in Europe was estimated to be 1 per 150,000.

Ataxia Telangiectasia Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Ataxia Telangiectasia market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Ataxia Telangiectasia market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Ataxia Telangiectasia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Ataxia Telangiectasia Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ataxia Telangiectasia market or expected to be launched during the study period. The analysis covers Ataxia Telangiectasia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Ataxia Telangiectasia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/ataxia-telangiectasia-at-market

Ataxia Telangiectasia Therapeutics Analysis

The dynamics of the Ataxia-Telangiectasia (A-T) market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies and incremental healthcare spending worldwide.

Some of the key companies in the Ataxia Telangiectasia (AT) market include:

  • EryDel

  • IntraBio

And many others.

Ataxia Telangiectasia (AT) Therapies covered in the report include:

  • EryDex System

  • IB1001

And others. 

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/ataxia-telangiectasia-at-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Ataxia Telangiectasia Competitive Intelligence Analysis

4. Ataxia Telangiectasia Market Overview at a Glance

5. Ataxia Telangiectasia Disease Background and Overview

6. Ataxia Telangiectasia Patient Journey

7. Ataxia Telangiectasia Epidemiology and Patient Population

8. Ataxia Telangiectasia Treatment Algorithm, Current Treatment, and Medical Practices

9. Ataxia Telangiectasia Unmet Needs

10. Key Endpoints of Ataxia Telangiectasia Treatment

11. Ataxia Telangiectasia Marketed Products

12. Ataxia Telangiectasia Emerging Therapies

13. Ataxia Telangiectasia Seven Major Market Analysis

14. Attribute Analysis

15. Ataxia Telangiectasia Market Outlook (7 major markets)

16. Ataxia Telangiectasia Access and Reimbursement Overview

17. KOL Views on the Ataxia Telangiectasia Market.

18. Ataxia Telangiectasia Market Drivers

19. Ataxia Telangiectasia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/ataxia-telangiectasia-at-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

 

Other Latest Healthcare Report by DelveInsight

Cerebral Infarction Market
“Cerebral Infarction Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Cerebral Infarction Market size, share, and trends in the 7MM. Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

  Categories: